SYK · Earnings call · 2026Q3T · Full report

Pricing and Market Competition

STRYKER CORP · 2026-10-29 · Importance 24 · Surprise 14

Management expects modest pricing across Stryker’s portfolio, with positive price likely coming more from MedSurg and slightly negative price in ortho. The company is seeking to hold as much orthopaedic pricing as possible, broadly consistent with the prior year. Management described normal contracting as a stable pricing environment and said bulk-sale pricing activity discussed in the market does not apply to Stryker.

Key facts

• Stryker expects modest price across its portfolio for the year, with positive price primarily from MedSurg and slightly negative price in orthopedics, similar to last year.
• Stryker does not conduct bulk sales and reports its prices; management described the normal-contracting pricing environment as stable.